Valuation Photocure ASA OTC Markets

Stocks

Delayed OTC Markets 19:24:53 11/09/2026 +04			5-day change	1st Jan Change
5.650 ^USD	-5.99%		-5.99%	-19.29%

08-16	Photocure Sees Potential in US FDA's Proposed Reclassification of Cystoscopy Systems	MT
08-14	Photocure ASA Initiates FDA Proposal To Reclassify Blue Light Cystoscopy Systems From Class III To Class II	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,769	2,895	1,827	1,681	1,900	1,375	-	-
Change	-	4.55%	-36.89%	-8.01%	13.04%	-27.6%	-	-
Enterprise Value (EV) ¹	2,483	2,639	1,567	1,387	1,661	1,206	1,218	1,216
Change	-	6.28%	-40.61%	-11.53%	19.77%	-27.36%	0.99%	-0.22%
P/E	-89.3x	-40.2x	6,740x	-344x	-1,190x	18.1x	65.5x	44.1x
PBR	-	-	-	-	-	3.82x	3.51x	3.3x
PEG	-	-0x	-67x	0x	17.9x	-0x	-0.9x	0.9x
Capitalization / Revenue	7.68x	7.73x	4.09x	3.42x	3.57x	2.09x	2.06x	1.91x
EV / Revenue	6.89x	7.05x	3.51x	2.82x	3.12x	1.83x	1.83x	1.69x
EV / EBITDA	136x	-107x	28.2x	28.2x	57.8x	11.4x	16.7x	14x
EV / EBIT	-426x	-53.9x	56.4x	68x	-2,229x	10.9x	28.8x	22.2x
EV / FCF	113x	-469x	35.4x	18.4x	95x	18.3x	108x	50x
FCF Yield	0.89%	-0.21%	2.82%	5.43%	1.05%	5.47%	0.93%	2%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.15	-2.66	0.01	-0.18	-0.06	2.83	0.78	1.16
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	360.5	374.5	446.2	491.7	532.6	658.3	666.3	720.3
EBITDA ¹	18.3	-24.63	55.49	49.19	28.73	105.7	73	86.67
EBIT ¹	-5.826	-49	27.81	20.4	-0.745	110.3	42.33	54.67
Net income ¹	-30.9	-71.86	0.267	-4.81	-1.519	76.33	21	31.67
Net Debt ¹	-285.4	-255.6	-259.5	-293.9	-238.9	-169	-157	-159.7
Reference price ²	102.70	106.80	67.40	62.00	71.40	51.10	51.10	51.10
Nbr of stocks (in thousands)	26,960	27,106	27,106	27,106	26,607	26,917	-	-
Announcement Date	23/02/22	23/02/23	21/02/24	19/02/25	18/02/26	-	-	-

¹NOK in Million²NOK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.3x	11.75x	23.82x	0.61%	1,013B
JOHNSON & JOHNSON	29.72x	6.61x	18.51x	2.01%	644B
ABBVIE INC.	33.26x	7.79x	16.1x	2.61%	465B
ROCHE HOLDING AG	19.53x	4.77x	11.83x	2.78%	352B
NOVARTIS AG	19.64x	5.13x	12.73x	3.13%	264B
ASTRAZENECA PLC	20.94x	4.32x	12.33x	2.04%	253B
AMGEN INC.	23.76x	6.28x	11.19x	2.69%	203B
NOVO NORDISK A/S	12.28x	4.47x	9.35x	4.09%	188B
GILEAD SCIENCES, INC.	-44.25x	6.45x	25.21x	2.25%	181B
Average	16.35x	6.40x	15.67x	2.47%	395.97B
Weighted average by Cap.	23.51x	7.63x	17.62x	2.01%